Swayamprava Satapathy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Swayamprava Satapathy has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Sachidananda Behera
Central University of Kerala, India
1 shared publication - V. B. Sameer Kumar
Central University of Kerala, India
1 shared publication - Vikash Kumar Nayak
Central University of Kerala, India
1 shared publication
Latest Publications
- Open Access
- 21 April 2026
- Published by MDPI AG in Preprints.org
Oncology Meets Virology: Exploring Viral Contributions to Cancer Development and Therapy
Viruses contribute to a substantial fraction of human cancers globally, with an estimated 12–15% of all cancer cases being linked to viral infections. This review synthesizes the current understanding of oncogenic viruses, their mechanisms of viral carcinogenesis, and the types of cancers associated with different viral pathogens. We explore the evolving therapeutic landscape, including vaccines, immunotherapies, and oncolytic virotherapy, and discuss the latest advances in clinical trials. The review also examines the challenges of viral cancer treatment, such as immune evasion and resistance to therapies, and looks forward to promising future directions in personalised medicine, advanced viral therapies, and drug discovery. The intersection of virology and oncology offers new opportunities for cancer prevention and treatment that could transform patient outcomes globally.
- 21 April 2026
- Published by MDPI AG in Preprints.org
Open AccessOncology Meets Virology: Exploring Viral Contributions to Cancer Development and Therapy
Viruses contribute to a substantial fraction of human cancers globally, with an estimated 12–15% of all cancer cases being linked to viral infections. This review synthesizes the current understanding of oncogenic viruses, their mechanisms of viral carcinogenesis, and the types of cancers associated with different viral pathogens. We explore the evolving therapeutic landscape, including vaccines, immunotherapies, and oncolytic virotherapy, and discuss the latest advances in clinical trials. The review also examines the challenges of viral cancer treatment, such as immune evasion and resistance to therapies, and looks forward to promising future directions in personalised medicine, advanced viral therapies, and drug discovery. The intersection of virology and oncology offers new opportunities for cancer prevention and treatment that could transform patient outcomes globally.